In patients with Stage 3 and 4 CKD, we found that [PTH] varied directly with EP/Ccr and [P]s before administration of sevelamer or a placebo, but with EP/Ccr alone after treatment [17]. The gene discussed is PTH; the disease is chronic kidney disease.